BIOMAT Database Logo BIOMAT Database Logo

[Treatment of disorders of cardiac rhythm with beta-adrenoblockaders]. 1985

I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010096 Oxprenolol A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety. Coretal,Koretal,Oxprenolol Hydrochloride,Slow Trasicor,Tevacor,Trasicor,Hydrochloride, Oxprenolol,Trasicor, Slow
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ
[Treatment of cardiac rhythm disorders with beta-receptor-blocking agents].
May 1969, Medizinische Klinik,
I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ
[Cardiac rhythm disorders. Treatment with LB 46, a pure beta-blocking agent].
February 1972, La Nouvelle presse medicale,
I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ
[Treatment of cardiac rhythm disorders with panangin].
October 1973, Kardiologiia,
I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ
[Treatment of cardiac rhythm disorders with disopyramide].
July 1968, Coeur et medecine interne,
I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ
[Treatment of cardiac rhythm disorders with ajmaline].
January 1960, Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung,
I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ
[Treatment of cardiac rhythm disorders].
January 1975, Terapevticheskii arkhiv,
I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ
[Treatment of cardiac rhythm disorders with electrical depolarization].
December 1972, Vrachebnoe delo,
I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ
[Emergency treatment of cardiac rhythm disorders].
July 1968, Coeur et medecine interne,
I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ
[Modern treatment of cardiac rhythm disorders].
February 1970, Revue medicale de la Suisse romande,
I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ
[The treatment of cardiac rhythm disorders].
February 1966, Medizinische Klinik,
Copied contents to your clipboard!